FDA inspection
Azurity Pharmaceuticals, Inc.: FDA inspection ending Mar 2, 2023
FDA inspection 1199279 · Wilmington, MA
Key facts
| Inspection ID | 1199279 |
|---|---|
| Firm | Azurity Pharmaceuticals, Inc. |
| FEI number | 3003395329 |
| Address | 841 Woburn St |
| City | Wilmington |
| State | MA |
| ZIP | 01887-3414 |
| Fiscal year | 2023 |
| Inspection end date | Mar 2, 2023 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 656489 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data